rs2107538

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000605509.2(CCL5):​c.-65G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.26 in 163,666 control chromosomes in the GnomAD database, including 6,602 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.27 ( 6325 hom., cov: 32)
Exomes 𝑓: 0.19 ( 277 hom. )

Consequence

CCL5
ENST00000605509.2 5_prime_UTR

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.426

Publications

254 publications found
Variant links:
Genes affected
CCL5 (HGNC:10632): (C-C motif chemokine ligand 5) This gene is one of several chemokine genes clustered on the q-arm of chromosome 17. Chemokines form a superfamily of secreted proteins involved in immunoregulatory and inflammatory processes. The superfamily is divided into four subfamilies based on the arrangement of the N-terminal cysteine residues of the mature peptide. This chemokine, a member of the CC subfamily, functions as a chemoattractant for blood monocytes, memory T helper cells and eosinophils. It causes the release of histamine from basophils and activates eosinophils. This cytokine is one of the major HIV-suppressive factors produced by CD8+ cells. It functions as one of the natural ligands for the chemokine receptor chemokine (C-C motif) receptor 5 (CCR5), and it suppresses in vitro replication of the R5 strains of HIV-1, which use CCR5 as a coreceptor. Alternative splicing results in multiple transcript variants that encode different isoforms. [provided by RefSeq, Jul 2013]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000605509.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.428 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000605509.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CCL5
ENST00000605509.2
TSL:3
c.-65G>A
5_prime_UTR
Exon 1 of 4ENSP00000474141.2P13501
ENSG00000270240
ENST00000605548.2
TSL:3
n.184-3606C>T
intron
N/A
ENSG00000270240
ENST00000788495.1
n.257+702C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.265
AC:
40212
AN:
151968
Hom.:
6290
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.433
Gnomad AMI
AF:
0.226
Gnomad AMR
AF:
0.235
Gnomad ASJ
AF:
0.189
Gnomad EAS
AF:
0.343
Gnomad SAS
AF:
0.302
Gnomad FIN
AF:
0.178
Gnomad MID
AF:
0.190
Gnomad NFE
AF:
0.180
Gnomad OTH
AF:
0.231
GnomAD4 exome
AF:
0.191
AC:
2210
AN:
11580
Hom.:
277
Cov.:
0
AF XY:
0.192
AC XY:
1129
AN XY:
5884
show subpopulations
African (AFR)
AF:
0.368
AC:
117
AN:
318
American (AMR)
AF:
0.225
AC:
449
AN:
1996
Ashkenazi Jewish (ASJ)
AF:
0.195
AC:
37
AN:
190
East Asian (EAS)
AF:
0.328
AC:
245
AN:
746
South Asian (SAS)
AF:
0.243
AC:
197
AN:
810
European-Finnish (FIN)
AF:
0.0900
AC:
18
AN:
200
Middle Eastern (MID)
AF:
0.200
AC:
6
AN:
30
European-Non Finnish (NFE)
AF:
0.155
AC:
1043
AN:
6728
Other (OTH)
AF:
0.174
AC:
98
AN:
562
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
85
170
256
341
426
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.265
AC:
40309
AN:
152086
Hom.:
6325
Cov.:
32
AF XY:
0.265
AC XY:
19740
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.434
AC:
17970
AN:
41452
American (AMR)
AF:
0.235
AC:
3597
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.189
AC:
656
AN:
3468
East Asian (EAS)
AF:
0.342
AC:
1773
AN:
5180
South Asian (SAS)
AF:
0.303
AC:
1457
AN:
4814
European-Finnish (FIN)
AF:
0.178
AC:
1883
AN:
10582
Middle Eastern (MID)
AF:
0.197
AC:
58
AN:
294
European-Non Finnish (NFE)
AF:
0.180
AC:
12221
AN:
67996
Other (OTH)
AF:
0.232
AC:
488
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1407
2815
4222
5630
7037
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
402
804
1206
1608
2010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.273
Hom.:
2898
Bravo
AF:
0.276
Asia WGS
AF:
0.308
AC:
1070
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
1.7
DANN
Benign
0.79
PhyloP100
-0.43
PromoterAI
0.26
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2107538;
hg19: chr17-34207780;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.